Fibroblast Growth Factor Receptor 4 Promotes Triple‐Negative Breast Cancer Progression via Regulating Fatty Acid Metabolism Through the AKT/RYR2 Signaling
Jinhui Ye, Song Wu, Qiang Quan, Feng Ye, Jinhui Zhang, Cailu Song, Yidan Fan, Huijiao Cao, Hailin Tang, Jianfu Zhao · 2024
Read Fibroblast Growth Factor Receptor 4 Promotes Triple‐Negative Breast Cancer Progression via Regulating Fatty Acid Metabolism Through the AKT/RYR2 Signaling by Jinhui Ye, Song Wu, Qiang Quan, Feng Ye, Jinhui Zhang, Cailu Song, Yidan Fan, Huijiao Cao, Hailin Tang, Jianfu Zhao (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11631837.txt.
Description
Jinhui Ye and co-authors present a 2024 study of a growth signal dock that drives the harshest breast cancer kind. Triple-negative tumors lack the usual drug targets, so fresh drivers matter. The dock, FGFR4, ran high in breast tumors and tracked with poor odds. In cell tests, raising or blocking the dock sped or slowed tumor growth, spread, and survival moves.
Gene hunts tied the dock to fat burning paths, run through a known signal chain and a calcium channel gene. A dock-blocking drug and a chain-waking drug let the team test each link. Fat fuel, it seems, is part of how this dock feeds the cancer. Blocking it starves two fires at once. The chain gives drug makers a paired target.
Catalog record
| CREATOR | Jinhui Ye, Song Wu, Qiang Quan, Feng Ye, Jinhui Zhang, Cailu Song, Yidan Fan, Huijiao Cao, Hailin Tang, Jianfu Zhao |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |